Pharma Focus Asia

Minaris Regenerative Medicine Opens New Manufacturing Sites in Europe and Asia

Introduction:

Minaris Regenerative Medicine plans to invest US$64.5 million to open new manufacturing facilities in Asia and Europe. This expansion increases the cell and gene manufacturing capabilities.

Features:

The project laid with an investment of US$64.5 million will expand the manufacturing sites of both Europe and Asia.

European Facility Expansion:
The European facility constructed with an US$40.7 million will cover an area of 6,650 sqm. This additional investment doubles the size of the existing capacity in Europe by further adding clean rooms, quality control laboratories, warehousing, cryo-storage, and office space.

European new state of the art facility will be constructed adjacent to the existing site in Ottobrunn near Munich.

The new manufacturing facility will be committed to clinical and commercial manufacturing as well as development services for cell and gene therapies.

It is expected that the new facility will open in 2023.

Asian site expansion:

The investment of US$23.8 million is planned to launch a center for cancer immunotherapy and somatic stem cells. The new facility consisting of an additional 4,000 sqm will be opened near to the current facility.

This expansion is planned to double the capacity of regenerative medicine for commercial manufacturing.

The new facility is set to begin its operations in October 2022.

Specifications:

NameMinaris Regenerative Medicine
TypeExpansion of Manufacturing Facility in Europe and Asia
BudgetUS$64.5 million
YearEuropean Site Expansion (2023), Asian site expansion (2022)
Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024ISPE Singapore Affiliate Conference & Exhibition 2024Rehab Expo 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024